Zantac Cancer Lawsuit

We are not medical professionals, but all of our information comes from reputable sources such as the FDA. If you are suffering from side effects that you think were caused by taking Zantac, please consult your health care professional immediately before contacting us.

Important information and FAQs about the recent Zantac recall

What is ranitidine and why are ranitidine products being recalled?

Ranitidine is an antacid that used to treat and prevent heartburn. The most common brand name of ranitidine is Zantac. Previously a prescription was needed to buy Zantac but the drug became available over-the-counter in the early 2000s.

The product is now being recalled by the FDA because extensive laboratory testing found high levels of N-nitrosodimethylamine (NDMA) present in the drug. These levels can increase based on the age of the drug and if the product is stored in higher temperatures, such as during shipping and distribution.

What is N-nitrosodimethylamine and why wasn’t this found earlier?

N-nitrosodimethylamine is more commonly known as NDMA. NDMA is a probably human carcinogen that in high doses can lead to multiple different types of cancer. The most common forms of cancer found in patients who’ve taken Zantac for more than a year are those found throughout the digestive track.

Levels of NDMA have always been present in this drug, as well as food, and water. The FDA has found that these low levels of NDMA that are commonly ingested do not pose an increased cancer (those under 96 nanograms), however, sustained higher levels of exposure may increase the risk of cancer in humans.

What is the risk to me for having taken Zantac?

The FDA has declared that consumers should stop taking any prescription or over-the-counter ranitidine products immediately and to consult a health care professional to discuss alternative medications that do not contain NDMA.

Again, at low levels, the NDMA does not seem to pose a threat of an increased cancer risk in humans. If you have been taking Zantac for an extended period of time, have stored your medication in an area that is over the recommended temperature and/or have taken more than the recommended dosage, please contact your doctor.

Find more information about the types of cancer Zantac may cause here.

How do I know if I have a case against the drug manufacturers?

  1. Have you taken Zantac for more than a year?
  2. Did you develop cancer after you started taking the drug?

If you answered yes to these two question you may have a case.

Forester Haynie is currently looking for people that have had prolonged exposure to Zantac and have developed any of the following cancers: stomach cancer, cancer in the intestines, esophageal cancer, liver cancer, or colorectal cancer.

The FDA has provided more information for consumers on NDMA exposure and the recall on ranitidine (Zantac) products.

Please contact us today to see if you have a case.

The U.S. Food and Drug Administration … announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac).

U.S. Food and Drug Administration Press Release

Free Zantac Cancer Lawsuit Case Evaluation

Image owned and copyrighted by Kratom IQ: